We investigated @ AML patients with a median age of @years and ( @ ) cytogenetically normal AML ( CN-AML ) , ( @ ) monoallelic ( moCEBPA ) or biallelic ( biCEBPA ) CEBPA mutation , and ( @ ) intensive induction treatment .